only life-saving treatment being kidney transplantation . Importantly, most transplanted patients have, thus far, not developed extrarenal complications, suggesting that the mutated gene product is highly specific for kidney development and/or glomerular filtration function. However, about 20% of the patients have developed posttransplantation nephrosis, the cause of which is unknown (Laine et al., 1993; .
Due to its high specificity for the glomerular filtration process, NPHS1 provides a unique model disease for studies on this important kidney function. Since there was no strong candidate gene for the disease, we have used the positional cloning approach in our attempts to identify the NPHS1 gene, and have localized the gene to a 150 kb region on chromosome 19q13.1 (Kestilä et al., 1994b; Mä nnikkö et al., 1995; this study) . In the present study, we have identified a novel gene in the critical region and shown it to be mutated in NPHS1. The gene product is a novel transmembrane member of the immunoglobulin superfamily, which in the human embryo shows a high expression level in renal glomeruli. between markers D19S208 and D19S224 were isolated Olsen et al., 1996) . Based on the Identification of the NPHS1 Gene significant linkage disequilibrium observed with D19S608
Haplotype analyses of chromosomes have revealed and D19S610, as well as the new microsatellite martwo major classes in Finnish NPHS1 patients (Mä nnikkö kers D19S1173, D19S1175, and D19S1176 identified in et al., 1995; this study) . The first one containing hapthis study, the NPHS1 gene was fine-mapped between lotypes 1-1-1-6-G-2-8-9 and 1-1-1-6-G-6-4-2 (markers D19S1175 and D19S608, in close vicinity to D19S1176 D19S1173, D19S1175, D19S1176, D19S610, RFLP of and D19S610 (Figure 1 ). Southern hybridization analyses gene B, D19S608, D19S224, and D19S220, respectively) of NPHS1 patients' DNA with genomic clones did not is the most common one found in 78% of Finnish NPHS1 reveal variations, suggesting that the mutations causing chromosomes. The second haplotype class, 3-5-3-6-A-NPHS1 do not represent major genomic rearrangements.
8-10-x, is found in 14% of cases (Table 1) . The remaining The 150 kb critical region was sequenced in its entirety, 8% of observed haplotypes show totally different allele and the sequence was searched for potential candidate combinations, and have been thought to represent other genes using exon prediction programs and data-base mutations. The two major haplotype classes could repsimilarity searches. Based on those analyses, the critical resent the same mutation, because they both share alregion was estimated to include over 100 potential exlele 6 of D19S610. However, the present results demonons. Similarity searches revealed one previously known strated that they represent two different mutations. gene, i.e., APLP1 encoding an amyloid precursor-like Since Southern hybridization analyses did not reveal protein (Lenkkeri et al., 1998) , and eight distinct exany major gene rearrangements, we decided to systempressed sequence tags (ESTs). Together, the analyses atically search for the mutations by direct sequencing indicated the presence of at least ten novel genes in of PCR-amplified exon regions of, if necessary, all of the critical region.
the genes of this region. Using GRAIL and GENSCAN exon prediction pro-
The 17 exon APLP1 gene located distal to D19S610 grams and sequences from cDNAs, the exon/intron did not show variations between patients and controls, structures of five of the genes, NPHS1 (Figure 1 ), APLP1
and was excluded as the NPHS1 gene (Lenkkeri et al., (Lenkkeri et al., 1998) , A, B, and C (not shown) were 1998). Also, the novel genes A, B, and C containing 9, determined. Although steady-state transcript levels var-5, and 3 exons, respectively, did not have sequence ied, Northern analyses revealed expression of all of the variants segregating with NPHS1, and could similarly genes in kidney, and with the exception of NPHS1, also be excluded as genes causing NPHS1 (data not shown). in other tissues (not shown). Therefore, none of them A fourth novel gene NPHS1 located proximal to D19S610 could be excluded as the NPHS1 gene, and all were encoding a transcript of about 4.3 kb was shown to be strongly expressed in human embryonic and adult subjected to mutation analysis. 90-residue protein x-y-1-6-G-x-y-x 10 1-1-1-6-G-6-4-2 9
3-5-3-6-A-8-10-x 14 nt3325 (C→T) substitution Nonsense→truncated R1109X, Finminor x-5-2-y-x-y- kidneys, no clear signals being observed above backchromosomes with the haplotype 1-1-1-6-G-2-8-9 or 1-1-1-6-G-6-4-2 (total of 76 chromosomes). The second ground in other tissues (Figure 2 ). Therefore, this gene sequence variant found in the NPHS1 gene was a nonwas a strong candidate for NPHS1. Full-length cDNA sense mutation CGA→TGA in exon 26 (R1109X, Fin minor ), for the transcript was constructed using fetal kidney present in patients with the haplotype 3-5-3-6-A-8-10-x poly(A) mRNA (Clontech), and PCR primers were made (14 chromosomes), and two patients with different hapbased on the predicted exon structure. The gene was lotypes. A total of 108 parents and 54 healthy siblings found to have a size of 26 kb and to contain 29 exons were analyzed, none of them being homozygous or com- (Figure 1 ).
pound heterozygous for the two mutations identified Exon sequencing analyses revealed the presence of here. One out of 83 control individuals was heterozygous two major mutations in over 90% of NPHS1 chromofor the Finmajor mutation. somes (Table 1, Figure 3 ). The first mutation, a 2 bp Cases of NPHS1 have also been found outside Findeletion in exon 2, causes a frameshift resulting in the land. In this study, mutation search was carried out in generation of a stop codon within the same exon. This two North American NPHS1 patients. A homozygous two mutation [nt121(del2), Fin major] was found in all NPHS1 nucleotide insertion was found in exon 10 [nt1306(ins2)] in patient NA-1. Patient NA-2 was heterozygous for one nucleotide insertion in exon 24 [nt3250(insG)], carrying the Finmajor mutation in the another allele. Mutations observed in this study and their consequences in the gene product are described in Figure 3 and Table 1 .
Characterization of the NPHS1 Gene Product
The cDNA-predicted amino acid sequence of nephrin is 1,241 residues ( Figure 4A ), with a calculated molecular mass of 134,742 without posttranslational modifications. Based on several similarity comparison and protein structure prediction programs, it was predicted that the NPHS1 protein would be a transmembrane protein of the immunoglobulin superfamily. There is a tentative 22-residue N-terminal signal peptide, an extracellular seven SG doublets that are potential attachment sites
The tissues studied are marked above the filter, and molecular size markers (kb) are shown to the sides of the filters.
for heparan sulfate.
podocytes. No specific signals were obtained with the antisense control probe (data not shown).
Discussion
Several lines of evidence obtained in the present study suggest that the gene affected in congenital nephrotic syndrome of the Finnish type has been positionally cloned. First, the defective gene is located in the critical 150 kb region on chromosome 19q13.1 to which the gene has been localized using linkage disequilibrium analyses (Kestilä et al., 1994b; Mä nnikkö et al., 1995;  this study). Second, the two mutations identified in the study were shown to be present, either as homozygous or compound heterozygous mutations, in 90% of Finnish patients studied. Of the remaining patients, 8% had the major mutation in one allele, the mutation in the other allele being, as yet, unidentified. One patient who did not have either of the two mutations, has a unique haplotype and, therefore, probably carries a different mutation. In addition, two different frameshift mutations were found from North American NPHS1 patients. Third, individuals homozygous or compound heterozygous for the mutations were not found in control DNAs. Additional, indirect evidence was the strong and practically renal glomerulispecific expression of the gene, which implies involvement of the gene product in glomerular development or function.
Identification of the NPHS1 Gene
The present identification of the gene causing NPHS1 demonstrates the power of linkage disequilibrium analysis and direct DNA sequencing in the positional cloning insertions, or inversions, were found in patient DNAs, search for small mutations had to be initiated, if necesNorthern hybridization analysis carried out with poly(A) sary, in all of the 11 genes. Having determined the exon mRNA from four human embryonic and eight adult tisand cDNA sequences for the genes, methods such as sues revealed a high steady-state level of the NPHS1 SSCP and DGGE, which are frequently used for identifigene transcript in the kidney, but not notably in other cation of small mutations, were potential alternatives. tissues (Figure 2) . In situ hybridization carried out on However, our experience from search for small mutaa kidney sample from a 23-week-old human embryo tions in Alport syndrome (Barker et al., 1990 ; Tryggvarevealed intense expression signals in the glomeruli (Figson, 1996) suggests that these methods can frequently ure 5A). At higher magnification (Figure 5B) Knebelmann et al., 1996; Renieri et al., 1996) , while direct studies have supported association of analyzed families to the same chromosome 19 locus (Fuchshuber et al., sequencing of PCR-amplified exon regions has yielded 1996). Two frameshift mutations were identified in this over 80% detection (Martin et al., personal communicastudy in North American patients, and a spectrum of tion). We therefore decided to use direct sequencing of different mutations can be expected to be found in other exon regions to find the NPHS1 mutations. Although we NPHS1 patients of non-Finnish origin. had to sequence numerous exons of several genes, this
The identification of the NPHS1 gene and diseaserelatively soon resulted in the identification of two small causing mutations has immediate clinical significance, mutations in one gene.
as they have enabled the development of exact DNAbased diagnosis for NPHS1 and carrier screening. This Genetics of NPHS1 is particularly important, as we have recently demonCrucial components in the successful positional cloning strated that the screening method for NPHS1 based on of the NPHS1 gene were the small isolated population, measurements of alpha-fetoprotein levels in amniotic good clinical records, and an equal, high-quality health fluid can lead to false-positive results and subsequent care system that made it possible to reliably collect abortions of healthy NPHS1 carriers (Mä nnikkö et al., family samples. A typical situation in population isolates 1997). is that close to 100% of cases are caused by the same mutation, and this phenomenon can already be seen in Nephrin-A Putative Glomerulus-Specific haplotype analysis. Observed changes in the founder Cell Adhesion Receptor haplotype, caused by historical recombinations, can be Due to the high association of expression and pathology used to restrict the critical chromosomal region to a with glomeruli, the proximal part of the nephron, we short genomic segment. Thus, differences in the major have named the NPHS1 gene product nephrin. The role NPHS1 haplotype 1-1-1-6-G-2-8-9 enabled substantial of nephrin remains unknown, but it is likely to be an narrowing of the interval, leading to the isolation of the adhesion receptor and a signaling protein, as its domain NPHS1 gene. The Fin major mutation causes only 78% of structure resembles that of a large group of cell adhecases, in contrast to many other "Finnish diseases" with sion receptors belonging to the immunoglobulin super-95%-98% prevalence of major disease alleles (Ikonen family (Brü mmendott and Rathjen, 1994). et al., 1991; Vesa et al., 1995; Hö glund et al., 1996) .
The Ig-like modules of nephrin are all of type C2, which However, the two main NPHS1-causing mutations charis particularly found in proteins participating in cell-cell acterized in this study together represent 94% of Finnish or cell-matrix interactions. The cytosolic domain has no cases.
significant homology with other known proteins. How-NPHS1 is enriched in the Finnish population, but sevever, it contains nine tyrosines, some of which could eral cases have been found elsewhere. Considerable become phosphorylated during ligand binding of nephrin. immigration from Finland to Minnesota has also caused The crucial role for the intracellular domain of nephrin the spread of NPHS1 to the USA (Norio, 1966; Mahan is emphasized by the fact that the Fin minor mutation, which et al., 1984). In addition, several NPHS1 cases have been results in the loss of 132 out of 155 residues of this domain, results in full-blown NPHS1. diagnosed in different European countries, and linkage
The ultimate filtration barrier for plasma macromolecules is located in the diaphragm covering the slit pores between the foot processes (Kasinath and Kanwar, 1993) . In NPHS1 and nephrotic syndromes of other causes, fusion of the foot processes is a general finding, and the structure or function of the slit pores is somehow affected with proteinuria as a result. It is possible that the plasma membrane protein nephrin is important for maintaining the integrity of the foot processes of glomerular epithelial cells, or is crucial for their anchorage to components of the GBM.
Conclusions
The identification of the NPHS1 gene will immediately find applications for diagnosis of the disease. Studies on the gene product nephrin, a putative cell-adhesion and signaling receptor, may also provide a key to new fundamental knowledge on the molecular mechanisms of glomerular filtration, which despite decades of research are still poorly understood. As abnormal function of the filtration barrier is a major complication in many clinically important kidney diseases, such as diabetic nephropathy, nephrotic syndromes, and glomerulonephritides, the present work is likely to have a significant impact on clinical nephrology. However, more information about nephrin and its function needs to be generated. Immediate questions relate to the developmental expression and location of the protein, which would require the generation of antibodies and nucleotide probes for studies in animal and cell culture systems. have been shown to interact with extracellular matrix and D19S608 has been reported previously (Olsen et al., 1996) .
(ECM) proteins. For example, the myelin-associated gly-DNA of cosmid clones F19541, R33502, F15549, R28051, F19399, coprotein MAG, whose extracellular domain contains R31158, and R31874 was mechanically sheared by nebulization, five Ig-like modules, interacts with different types of and fragments of 1000-2000 bp were isolated and subcloned into collagens and glycosaminoglycans (Fahrig et al., 1987) .
M13 phage, prior to random sequencing using ABI377 automated DNA sequencers.
Furthermore, the axonal glycoprotein F11 and the deleted in colorectal cancer (DCC) protein have both been molecular biology server (Appel et al., 1994) . The mutation search on the manuscript. This study was supported in part by grants was performed by comparing patient sequences to the normal genofrom the Sigrid Juselius Foundation, The Academy of Finland, The mic sequence using the FASTA program of the GCG package (GeSwedish Medical Research Council, and Hedlund's Foundation. netics Computer Group, 1996) .
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